Company HealthSouth Corp Nyse
Equities
US4219243098
Healthcare Facilities & Services
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Inpatient
97.8
%
| 4,252 | 97.8 % | 4,694 | 97.8 % | +10.40% |
Outpatient and Other
2.2
%
| 97 | 2.2 % | 107 | 2.2 % | +10.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Puerto Rico
100.0
%
| 4,349 | 100.0 % | 4,801 | 100.0 % | +10.41% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 31/12/92 |
Douglas Coltharp
DFI | Director of Finance/CFO | 62 | 05/05/10 |
Chief Tech/Sci/R&D Officer | 64 | - | |
Investor Relations Contact | - | 06/09/21 | |
Brad Kennedy
PRN | Corporate Officer/Principal | - | - |
Troy DeDecker
PRN | Corporate Officer/Principal | - | - |
John Darby
LAW | General Counsel | 59 | 17/02/16 |
Crissy Carlisle
PRN | Corporate Officer/Principal | - | 31/01/05 |
Sandy Murvin
PRN | Corporate Officer/Principal | - | 30/09/07 |
Andrew Price
AUD | Comptroller/Controller/Auditor | 57 | 31/05/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leslye Katz
BRD | Director/Board Member | 69 | 24/01/13 |
Director/Board Member | 62 | 31/12/19 | |
Director/Board Member | 68 | 30/09/21 | |
Mark Tarr
CEO | Chief Executive Officer | 62 | 31/12/92 |
Ted Christie
BRD | Director/Board Member | 53 | 11-26 |
Joan Herman
BRD | Director/Board Member | 70 | 24/01/13 |
Director/Board Member | 69 | 10/12/17 | |
Director/Board Member | 70 | 31/12/19 | |
Kevin O'Connor
BRD | Director/Board Member | 56 | 29/03/22 |
Director/Board Member | 55 | 31/12/19 |
Company contact information
Encompass Health Corp.
9001 Liberty Parkway
35242, Birmingham
+205 967 7116
http://www.encompasshealth.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+14.23% | 81.68B | |
-28.62% | 69.23B | |
+9.72% | 29.08B | |
-11.56% | 16.88B | |
-0.43% | 16.85B | |
-0.84% | 15.15B | |
+3.42% | 12.62B | |
+28.75% | 12.47B | |
-30.70% | 11.89B |